Minesh P Mehta Selected Research

Minesh P Mehta Research Topics

Disease

98	Neoplasms (Cancer) 10/2022 - 08/2002
88	Brain Neoplasms (Brain Tumor) 10/2022 - 06/2002
55	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2004
38	Glioma (Gliomas) 02/2022 - 06/2002
26	Neoplasm Metastasis (Metastasis) 01/2022 - 09/2005
24	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 02/2003
10	Lung Neoplasms (Lung Cancer) 01/2022 - 02/2003
5	Meningioma (Meningiomas) 06/2022 - 09/2010
5	Fatigue 02/2022 - 08/2010
5	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 01/2003
4	Necrosis 01/2022 - 06/2015
4	Pneumonia (Pneumonitis) 01/2021 - 11/2010
4	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2016
4	Lymphoma (Lymphomas) 01/2018 - 02/2007
4	Thrombocytopenia (Thrombopenia) 01/2018 - 07/2004
4	Oligodendroglioma 05/2017 - 09/2012
4	Cognitive Dysfunction 01/2015 - 11/2004
4	Disease Progression 02/2014 - 06/2008
3	Adenocarcinoma 12/2021 - 10/2016
3	Neurologic Manifestations (Neurological Manifestations) 11/2020 - 01/2010
3	Hypertension (High Blood Pressure) 01/2020 - 10/2008
3	Esophageal Neoplasms (Esophageal Cancer) 01/2017 - 08/2016
3	Neutropenia 02/2014 - 01/2003
3	Radiation Pneumonitis 12/2013 - 07/2011
2	Malignant Mesothelioma 04/2022 - 05/2021
2	Epilepsy (Aura) 02/2022 - 03/2016
2	Adenocarcinoma of Lung 01/2022 - 10/2016
2	Sepsis (Septicemia) 01/2021 - 11/2020
2	Pain (Aches) 11/2020 - 12/2005
2	Wounds and Injuries (Trauma) 08/2020 - 01/2017
2	Gliosarcoma 01/2020 - 12/2012
2	Lymphopenia (Lymphocytopenia) 01/2018 - 08/2010
2	Diarrhea 01/2018 - 01/2004
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2018 - 02/2007
2	Esophagitis 01/2016 - 11/2010
2	Edema (Dropsy) 04/2014 - 01/2010

Drug/Important Bio-Agent (IBA)

28	Temozolomide (Temodar)FDA LinkGeneric 04/2021 - 04/2003
12	motexafin gadoliniumIBA 11/2011 - 08/2002
8	ErbB Receptors (EGF Receptor)IBA 01/2022 - 12/2009
8	Biological ProductsIBA 01/2022 - 07/2004
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2004
7	Bevacizumab (Avastin)FDA Link 01/2021 - 01/2014
6	Procarbazine (Matulane)FDA Link 10/2022 - 09/2012
6	Vincristine (Oncovin)FDA LinkGeneric 10/2022 - 09/2012
6	Lomustine (CCNU)FDA Link 10/2022 - 09/2012
5	Pharmaceutical PreparationsIBA 02/2022 - 01/2006
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 07/2011
5	Anticonvulsants (Antiepileptic Drugs)IBA 03/2016 - 01/2004
4	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2022 - 09/2005
4	Tyrosine Kinase InhibitorsIBA 01/2021 - 08/2010
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2020 - 05/2012
4	TOR Serine-Threonine KinasesIBA 01/2018 - 12/2009
4	Protons (Proton)IBA 11/2016 - 01/2016
4	Thalidomide (Thalomid)FDA Link 01/2013 - 05/2008
4	Carmustine (FIVB)FDA Link 11/2005 - 01/2004
3	Memantine (Namenda)FDA Link 01/2020 - 10/2013
3	Phosphotransferases (Kinase)IBA 01/2020 - 05/2012
3	Sorafenib (BAY 43-9006)FDA Link 01/2020 - 12/2012
3	DNA (Deoxyribonucleic Acid)IBA 09/2017 - 02/2012
3	Alkylating AgentsIBA 03/2014 - 04/2003
3	SteroidsIBA 03/2012 - 01/2007
3	EnzymesIBA 10/2011 - 01/2004
3	Lapatinib (GW572016)FDA Link 10/2011 - 01/2007
2	B7-H1 AntigenIBA 01/2022 - 01/2021
2	Endothelial Growth FactorsIBA 01/2022 - 07/2011
2	mesoglycanIBA 01/2021 - 01/2021
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021 - 08/2010
2	Hormones (Hormone)IBA 01/2021 - 01/2020
2	Estrogen ReceptorsIBA 01/2021 - 01/2020
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2020 - 10/2011
2	Histones (Histone)IBA 01/2020 - 04/2019
2	Lipase (Acid Lipase)FDA Link 01/2020 - 01/2018
2	Transaminases (Aminotransferases)IBA 01/2020 - 10/2008
2	TIC10 compoundIBA 10/2019 - 04/2019
2	Dexamethasone (Maxidex)FDA LinkGeneric 04/2019 - 01/2019
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2019 - 01/2004
2	tipifarnib (R115777)IBA 01/2018 - 12/2011
2	Everolimus FDA Link 01/2018 - 08/2013
2	MethyltransferasesIBA 09/2017 - 09/2008
2	Proteins (Proteins, Gene)FDA Link 04/2014 - 07/2011
2	Sirolimus (Rapamycin)FDA Link 04/2014 - 12/2009

Therapy/Procedure

138	Radiotherapy 10/2022 - 06/2002
69	Therapeutics 06/2022 - 01/2003
41	Drug Therapy (Chemotherapy) 10/2022 - 01/2003
18	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 02/2014 - 02/2003
7	Re-Irradiation 06/2022 - 06/2008
5	Conformal Radiotherapy 08/2011 - 03/2006
4	Immunotherapy 01/2022 - 06/2015
4	Length of Stay 11/2021 - 08/2016
4	Chemoradiotherapy 03/2016 - 09/2004
3	Particle Accelerators 10/2021 - 12/2005
3	Retreatment 01/2021 - 01/2010
3	Cranial Irradiation 05/2014 - 12/2010
2	Patient Readmission 11/2021 - 08/2020
2	Craniotomy 11/2021 - 10/2018
2	Molecular Targeted Therapy 01/2021 - 12/2012
2	Salvage Therapy 11/2018 - 01/2018
2	Brachytherapy 11/2018 - 05/2016
2	Drug Tapering 11/2016 - 08/2010
2	Proton Therapy 11/2016 - 08/2011